SONOMA PHARMACEUTICALS INC's ticker is SNOA and the CUSIP is 83558L204. A total of 22 filers reported holding SONOMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11 | -54.2% | 14,006 | -36.9% | 0.00% | – |
| Q2 2023 | $24 | -41.5% | 22,206 | -47.1% | 0.00% | – |
| Q1 2023 | $41 | -50.6% | 41,967 | -43.6% | 0.00% | – |
| Q4 2022 | $83 | -99.9% | 74,467 | -1.2% | 0.00% | – |
| Q3 2022 | $161,000 | -27.1% | 75,367 | -0.5% | 0.00% | – |
| Q2 2022 | $221,000 | -8.7% | 75,767 | +25.5% | 0.00% | – |
| Q1 2022 | $242,000 | -14.8% | 60,367 | -3.1% | 0.00% | – |
| Q4 2021 | $284,000 | -43.9% | 62,267 | -31.3% | 0.00% | -100.0% |
| Q3 2021 | $506,000 | -25.3% | 90,667 | -1.6% | 0.00% | 0.0% |
| Q2 2021 | $677,000 | -7.8% | 92,167 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $734,000 | +10.2% | 98,826 | +7.7% | 0.00% | 0.0% |
| Q4 2020 | $666,000 | -16.0% | 91,734 | -3.2% | 0.00% | 0.0% |
| Q3 2020 | $793,000 | +35.3% | 94,734 | +15.2% | 0.00% | 0.0% |
| Q2 2020 | $586,000 | +71.8% | 82,234 | +18.0% | 0.00% | – |
| Q1 2020 | $341,000 | +33.2% | 69,665 | +18.7% | 0.00% | – |
| Q4 2019 | $256,000 | -4.5% | 58,709 | +26.3% | 0.00% | – |
| Q3 2019 | $268,000 | -13.5% | 46,474 | +18.9% | 0.00% | – |
| Q2 2019 | $310,000 | – | 39,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 74,467 | $83 | 0.00% |
| Gradient Investments LLC | 31 | $35 | 0.00% |
| NewSquare Capital LLC | 10 | $11 | 0.00% |
| Allworth Financial LP | 65 | $73 | 0.00% |
| UBS Group AG | 2,926 | $3,277 | 0.00% |
| OSAIC HOLDINGS, INC. | 166 | $0 | 0.00% |
| US BANCORP \DE\ | 500 | $560 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 44 | $49 | 0.00% |
| WELLS FARGO & COMPANY/MN | 21 | $24 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |